Event Date/Time: Aug 04, 2012
End Date/Time: Aug 04, 2012
This symposium is intended to improve care of cancer patients by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy and targeted therapy of solid tumors and hematological malignancies, this symposium will focus on individualized therapy based on emerging agents currently in development, symptom control and management of toxicity issues, and practice guidelines and its impact on reimbursement issues. The format will include didactic lectures from known thought leaders, question and answer sessions, and ample opportunity for participant interaction with faculty. In-depth discussion of novel agents at various stages of clinical development will be given significant focus.